Ethicon Biosurgery, Division of Ethicon, Inc., a worldwide leader in hemostasis and sealing solutions, announced today that the U.S. Food and Drug Administration (FDA) has approved EVARREST™ Fibrin ...

LONDON, GREATER LONDON, UNITED KINGDOM, March 7, 2025 /EINPresswire / -- Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! How Has the ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved an additional indication for Evarrest, enabling the product to be used as an adjunct to ...

SOMERVILLE, N.J., Dec. 7, 2012 /PRNewswire/ -- Ethicon Biosurgery, Division of Ethicon, Inc., a worldwide leader in hemostasis and sealing solutions, announced today that the U.S. Food and Drug ...

Ethicon Biosurgery announced that the FDA has approved Evarrest Fibrin Sealant Patch, a topical product indicated for use with manual compression as an adjunct to hemostasis for soft tissue bleeding ...

Ethicon, a part of the family of Johnson & Johnson companies. announced that the US Food and Drug Administration (FDA) has approved an expanded indication for Evarrest Fibrin Sealant Patch, which ...

Chances of uncontrolled bleeding is common in liver surgeries and the newly developed Fibrin Sealant Patch contains specific protein that helps in clot formation. EVARREST Fibrin Sealant Patch, ...

Johnson & Johnson's ($JNJ) Ethicon division received clearance from the FDA for an expanded indication of its Evarrest patch, which can now be used to help control ...

Ethicon Biosurgery, a division of Ethicon, has announced it has received FDA approval for its EVARREST fibrin sealant patch, according to a news release (pdf). EVARREST is designed to aid in stopping ...

LONDON, GREATER LONDON, UNITED KINGDOM, January 24, 2025 /EINPresswire / -- Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! How has the ...